Dysphagia is a common disorder that affects the way you swallow. The swallowing process requires coordinated muscle movements and includes three phases. Those who suffer from dysphagia have a problem with one or more of these phases. Symptoms can include a hard time pushing food to the back of the throat and forming soft “balls” in the mouth.
Statistics:
The global dysphagia management market is estimated to account for US$ 5,040.7 Mn in terms of value by the end of 2028.
Get Free Sample Report With Latest Covid19 Analysis @
https://www.coherentmarketinsights.com/insight/request-sample/3612
Growing aging population is driving growth of global dysphagia management market over the forecast period. According to the U.S. Census Bureau, geriatric population in the U.S. is expected to reach 77 million by 2035.
Additionally, increasing number of smokers is also expected to support growth of the market. For instance, according to the World Health Organization, 1.337 billion people smoked tobacco worldwide in 2018.
North America region held dominant position in the global dysphagia management market in 2019, accounting for 36.1% share in terms of volume, followed by Europe.
Side effects and discomfort of dysphagia drugs and tubes are projected to hamper growth of the market. Long-term use of dysphagia drugs such as proton pump inhibitors is associated with certain threats such as increased risk of hip bone fracture owing to decreased absorption of calcium and iron and risk of opportunistic infections with S. pneumonia and C. defficile due to diminished natural gut flora. Moreover, use of nasogastric tubes or PEG tubes may lead to irritation to the throat, abdominal cramping, abdominal swelling, diarrhea, nausea, vomiting, and regurgitation of food and medicines.
Moreover, dysphagia is difficult to diagnose and this factor is expected to limit growth of the market. There are many causes for dysphagia, and in some cases, it is difficult to produce the etiology of the disease.
Request PDF Brochure with Latest Insights @
https://www.coherentmarketinsights.com/insight/request-pdf/3612
Key players are focusing on introducing OTC drugs for the treatment of dysphagia. For instance, majority of pharmaceutical companies in Western Europe such as Bayer AG and Johnson & Johnson are expanding into to OTC business as a contiguous out-of-pocket market.
Moreover, launch of standard definitions of dysphagia and malnutrition, in-depth assessment of link between causes and outcome of dysphagia, and importance on the need for efficient and accurate screening is also projected to support growth of the market.
Drugs segment in the global dysphagia management market was valued at US$ 268.9 Mn in 2019 and is expected to reach US$ 403.7 Mn by 2027 at a CAGR of 5.2% during the forecast period.
Market Trends/Key Takeaways
Lack of advanced therapies for dysphagia and lack of awareness regarding the disease are major issues in developing countries. In developing countries such as India, South Africa, and Mexico, patients find difficulties procuring nutritional solutions used in the management of dysphagia. Moreover, various patient remain undiagnosed due to lack of robust medical facilities in these countries.
The prevalence of dysphagia in patients suffering from unilateral vocal fold immobility is high. For instance, according to June 2019 study in the journal Otolaryngology–Head and Neck, the prevalence of symptomatic dysphagia ranged from 55.6% to 69.0% and the aspiration rate was 20.0% to 50.0% in patients suffering from unilateral vocal fold immobility.
Major players operating in the global dysphagia management market include, Eisai Co. Ltd., C. R. Bard, Inc. (Becton, Dickinson and Company), Hormel Health Labs, AstraZeneca, Cipla Ltd., Nestlé Health Science, Kent Precision Foods Group, Inc., Bracco Diagnostics Inc., Phagenesis Ltd., Nutricia Advanced Medical Nutrition, and Cook Medical Inc.
Major players focused on approval and launch of new products to expand their product portfolio. For instance, in January 2020, Phagenesis Ltd. received Breakthrough Device Designation from the U.S. Food and Drug Administration (FDA) for its Phagenyx System used for the treatment of neurogenic dysphagia.
In July 2019, Hormel Health Labs, a manufacturer of health and nutrition products, introduced Thick & Easy Coffee Sticks, for people suffering from dysphagia.
Reasons to Buy this Dysphagia Management Market Report
➡ Save time carrying out entry-level research by identifying the size, growth, and leading players in the emerging Dysphagia Management market
➡Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the emerging Dysphagia Management market
➡Leading company profiles reveal details of key Dysphagia Management market players emerging five operations and financial performance
➡Add weight to presentations and pitches by understanding the future growth prospects of the emerging Dysphagia Management market with five year historical forecasts
➡Compares data from North America, South America, Asia Pacific Europe and Middle East Africa, alongside individual chapters on each region .
Buy This Complete Business Report With Flat USD 2000 Off @
https://www.coherentmarketinsights.com/promo/buynow/3612
Table of Content
- Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
- Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snippet, By Product
- Market Snippet, By Indication
- Market Snippet, By Distribution Channel
- Market Snippet, By Region
- Coherent Opportunity Map (COM)
- Report Description
- Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Market Opportunities
- Impact Analysis
- Key Highlights
- Product launch
- PEST Analysis
- Regulatory Scenario
- Mergers and Acquisitions
- Market Dynamics
- Global Dysphagia Management Market, By Product, 2019 – 2027, (US$ Mn)
- Introduction
- Market Share Analysis, 2019 and 2027 (%)
- Y-o-Y Growth Analysis, 2017 – 2027
- Segment Trends
- Drugs
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
- Proton Pump Inhibitors
- Feeding Tubes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
- Naso-Gastric Tubes
- PEG tubes
- Nutritional Solutions
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
- Thickeners
- Beverages
- Purees
- Introduction
- Global Dysphagia Management Market, By Indication, 2019 – 2027, (US$ Mn)
- Introduction
- Market Share Analysis, 2019 and 2027 (%)
- Y-o-Y Growth Analysis, 2017 – 2027
- Segment Trends
- Oropharangeal Dysphagia
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
- Esophageal Dysphagia
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
- Introduction
- Global Dysphagia Management Market, By Distribution Channel, 2019 – 2027, (US$ Mn)
- Introduction
- Market Share Analysis, 2019 and 2027 (%)
- Y-o-Y Growth Analysis, 2017 – 2027
- Segment Trends
- Hospital Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
- Retail Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
- Drug Stores
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
- Specialty Clinics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
- Introduction
- Global Dysphagia Management Market, By Region, 2019 – 2027, (US$ Mn)
- Introduction
- Market Share Analysis, By Region, 2019 and 2027 (%)
- Y-o-Y Growth Analysis, For Regions, 2017–2026
- North America
- Market Size and Forecast, By Product, 2016 – 2027, (US$ Mn)
- Market Size and Forecast, By Indication, 2016 – 2027, (US$ Mn)
- Market Size and Forecast, By Distribution Channel, 2016 – 2027, (US$ Mn)
- Market Size and Forecast, By Country, 2016 – 2027, (US$ Mn)
- U.S.
- Canada
- Latin America
- Market Size and Forecast, By Product, 2016 – 2027, (US$ Mn)
- Market Size and Forecast, By Indication, 2016 – 2027, (US$ Mn)
- Market Size and Forecast, By Distribution Channel, 2016 – 2027, (US$ Mn)
- Market Size and Forecast, By Country, 2016 – 2027, (US$ Mn)
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- Market Size and Forecast, By Product, 2016 – 2027, (US$ Mn)
- Market Size and Forecast, By Indication, 2016 – 2027, (US$ Mn)
- Market Size and Forecast, By Distribution Channel, 2016 – 2027, (US$ Mn)
- Market Size and Forecast, By Country, 2016 – 2027, (US$ Mn)
- Germany
- U.K.
- France
- Italy
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- Market Size and Forecast, By Product, 2016 – 2027, (US$ Mn)
- Market Size and Forecast, By Indication, 2016 – 2027, (US$ Mn)
- Market Size and Forecast, By Distribution Channel, 2016 – 2027, (US$ Mn)
- Market Size and Forecast, By Country, 2016 – 2027, (US$ Mn)
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of APAC
- Middle East
- Market Size and Forecast, By Product, 2016 – 2027, (US$ Mn)
- Market Size and Forecast, By Indication, 2016 – 2027, (US$ Mn)
- Market Size and Forecast, By Distribution Channel, 2016 – 2027, (US$ Mn)
- Market Size and Forecast, By Country, 2016 – 2027, (US$ Mn)
- GCC
- Israel
- Rest of Middle East
- Africa
- Market Size and Forecast, By Product, 2016 – 2027, (US$ Mn)
- Market Size and Forecast, By Indication, 2016 – 2027, (US$ Mn)
- Market Size and Forecast, By Distribution Channel, 2016 – 2027, (US$ Mn)
- Market Size and Forecast, By Country, 2016 – 2027, (US$ Mn)
- South Africa
- Central Africa
- North Africa
- Introduction
- Competitive Landscape
- Company Profiles
- Eisai Co. Ltd.
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- C. R. Bard, Inc. (Becton, Dickinson and Company)
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Hormel Health Labs
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- AstraZeneca
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Cipla Ltd.
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Nestlé Health Science
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Kent Precision Foods Group, Inc.
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Bracco Diagnostics Inc.
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Phagenesis Ltd.
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Nutricia Advanced Medical Nutrition
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Cook Medical Inc.
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Eisai Co. Ltd.
- Company Profiles
- Section
- References
- Research Methodology
- About us and Sales Contact
About Us:
Coherent Market Insights is a global market intelligence and consulting organization that provides syndicated research reports, customized research reports, and consulting services. We are known for our actionable insights and authentic reports in various domains including aerospace and defense, agriculture, food and beverages, automotive, chemicals and materials, and virtually all domains and an exhaustive list of sub-domains under the sun. We create value for clients through our highly reliable and accurate reports. We are also committed in playing a leading role in offering insights in various sectors post-COVID-19 and continue to deliver measurable, sustainable results for our clients.
Contact:
Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
Email: sales@coherentmarketinsights.com
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027
Japan: +050-5539-1737
India: +91-848-285-0837